Pages that link to "Q43726212"
Jump to navigation
Jump to search
The following pages link to Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia (Q43726212):
Displaying 50 items.
- Neuroinflammation and psychiatric illness (Q21245244) (← links)
- Changes in region- and cell type-specific expression patterns of neutral amino acid transporter 1 (ASCT-1) in the anterior cingulate cortex and hippocampus in schizophrenia, bipolar disorder and major depression (Q24299332) (← links)
- The mGluR2/3 agonist LY379268 blocks the effects of GLT-1 upregulation on prepulse inhibition of the startle reflex in adult rats (Q24603020) (← links)
- Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia (Q24632939) (← links)
- The neurodevelopmental hypothesis of schizophrenia, revisited (Q24658343) (← links)
- Association study of polymorphisms in the excitatory amino acid transporter 2 gene (SLC1A2) with schizophrenia (Q24803364) (← links)
- Form and Function of Sleep Spindles across the Lifespan (Q26748715) (← links)
- Decreased gene expression of glial and neuronal glutamate transporters after chronic antipsychotic treatment in rat brain (Q28188520) (← links)
- NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development (Q28205016) (← links)
- GLT-1 upregulation impairs prepulse inhibition of the startle reflex in adult rats (Q28299852) (← links)
- Assessment of glutamate transporter GLAST (EAAT1)-deficient mice for phenotypes relevant to the negative and executive/cognitive symptoms of schizophrenia (Q30465586) (← links)
- Schizophrenia and sex associated differences in the expression of neuronal and oligodendrocyte-specific genes in individual thalamic nuclei (Q33306645) (← links)
- Association study of polymorphisms in the neutral amino acid transporter genes SLC1A4, SLC1A5 and the glycine transporter genes SLC6A5, SLC6A9 with schizophrenia (Q33353046) (← links)
- Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia (Q33696761) (← links)
- Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs (Q34338202) (← links)
- Abnormal partitioning of hexokinase 1 suggests disruption of a glutamate transport protein complex in schizophrenia (Q34406087) (← links)
- The importance of the excitatory amino acid transporter 3 (EAAT3) (Q34528594) (← links)
- Klotho sensitivity of the neuronal excitatory amino acid transporters EAAT3 and EAAT4. (Q34907600) (← links)
- Shared gene expression alterations in schizophrenia and bipolar disorder (Q34994225) (← links)
- Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophrenia (Q35657864) (← links)
- Chronic perinatal hypoxia reduces glutamate-aspartate transporter function in astrocytes through the Janus kinase/signal transducer and activator of transcription pathway (Q35754879) (← links)
- Cell-specific abnormalities of glutamate transporters in schizophrenia: sick astrocytes and compensating relay neurons? (Q35791075) (← links)
- Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement (Q36052481) (← links)
- N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives (Q36068372) (← links)
- The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention (Q36137988) (← links)
- Genetic tests of biologic systems in affective disorders. (Q36154264) (← links)
- Dysregulation of thalamic sensory "transmission" in schizophrenia: neurochemical vulnerability to hallucinations (Q36262534) (← links)
- The dynamics of DNA methylation in schizophrenia and related psychiatric disorders. (Q36465820) (← links)
- Deletion of adenosine A2A receptors from astrocytes disrupts glutamate homeostasis leading to psychomotor and cognitive impairment: relevance to schizophrenia (Q36468280) (← links)
- Reduced sleep spindles and spindle coherence in schizophrenia: mechanisms of impaired memory consolidation? (Q36580050) (← links)
- Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia (Q36609289) (← links)
- EAAT2 regulation and splicing: relevance to psychiatric and neurological disorders (Q36904469) (← links)
- Expression of equilibrative nucleoside transporter type 1 protein in elderly patients with schizophrenia (Q36937010) (← links)
- The effects of eszopiclone on sleep spindles and memory consolidation in schizophrenia: a randomized placebo-controlled trial. (Q37081701) (← links)
- Glutamatergic abnormalities of the thalamus in schizophrenia: a systematic review (Q37095356) (← links)
- Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia (Q37129963) (← links)
- Altered vesicular glutamate transporter expression in the anterior cingulate cortex in schizophrenia (Q37160608) (← links)
- Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia (Q37173934) (← links)
- Executive function, neural circuitry, and genetic mechanisms in schizophrenia (Q37480047) (← links)
- Thalamic nuclear abnormalities as a contributory factor in sudden cardiac deaths among patients with schizophrenia. (Q37763856) (← links)
- Changes in the expression of the glutamate transporter EAAT3/EAAC1 in health and disease (Q38155806) (← links)
- Antipsychotic treatment modulates glutamate transport and NMDA receptor expression (Q38248566) (← links)
- The thalamic reticular nucleus: a functional hub for thalamocortical network dysfunction in schizophrenia and a target for drug discovery (Q38317401) (← links)
- Sleep spindle deficits in antipsychotic-naïve early course schizophrenia and in non-psychotic first-degree relatives (Q38389616) (← links)
- Reduced Sleep Spindles in Schizophrenia: A Treatable Endophenotype That Links Risk Genes to Impaired Cognition? (Q38646427) (← links)
- PIP5K2A-dependent regulation of excitatory amino acid transporter EAAT3. (Q39818618) (← links)
- Modulation of hippocampal synaptic transmission by the kynurenine pathway member xanthurenic acid and other VGLUT inhibitors (Q39921706) (← links)
- Characterization of a Novel Mutation in SLC1A1 Associated with Schizophrenia (Q42154902) (← links)
- Update on the neurobiology of schizophrenia: a role for extracellular microdomains. (Q42968242) (← links)
- RNA-binding protein QKI regulates Glial fibrillary acidic protein expression in human astrocytes (Q43410195) (← links)